Pernix Therapeutics Holdings Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
25,635.30
35,286.00
148,315.00
169,590.00
77,141.00
Depreciation, Depletion & Amortization
8,676.30
32,999.00
94,695.00
86,215.00
73,335.00
Other Funds
804.40
3,205.00
2,267.00
23.00
112.00
Funds from Operations
18,188.80
1,587.00
10,511.00
39,238.00
2,438.00
Changes in Working Capital
11,656.40
10,483.00
4,238.00
22,737.00
3,501.00
Net Operating Cash Flow
6,532.40
8,896.00
14,749.00
16,501.00
5,939.00
Capital Expenditures
527.50
1,177.00
1,212.00
984.00
18.00
Sale of Fixed Assets & Businesses
19,619.60
1,355.00
-
-
2,000.00
Purchase/Sale of Investments
4,605.30
-
-
-
-
Net Investing Cash Flow
23,387.80
249,922.00
84,348.00
1,567.00
1,982.00
Issuance/Reduction of Debt, Net
25,297.00
261,290.00
122,249.00
21,483.00
1,465.00
Net Financing Cash Flow
24,231.20
260,234.00
120,377.00
1,692.00
402.00
Net Change in Cash
7,375.90
19,208.00
21,280.00
19,760.00
3,555.00
Free Cash Flow
7,059.90
7,719.00
15,961.00
17,485.00
5,957.00
Deferred Taxes & Investment Tax Credit
22,516.00
11,753.00
6,746.00
202.00
238.00
Net Assets from Acquisitions
309.60
254,950.00
87,986.00
583.00
-
Other Sources
-
4,850.00
4,850.00
-
-
Change in Capital Stock
261.40
2,149.00
395.00
19,814.00
1,979.00
About Pernix Therapeutics Holdings
View Profile
